COMP <GO>
ESCA vs PG // RETURN ON INVESTED CAPITAL (ROIC)
Escalade Incorporated (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: ESCA 7
— PG 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PG
LAST: $19.70 (-2.18%) • MKT CAP: $277.2M
roic
8.00%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
roic
25.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESCA VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESCA | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.90% | 51.20% | -24.30 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 8.00% | 25.40% | -17.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.8x | 16.2x | -2.40 | ESCA | /valuation <GO> |
| Free Cash Flow Yield | 10.28% | 3.77% | +6.51 | ESCA | /fcf-yield <GO> |
| Operating Margin | 7.80% | 24.30% | -16.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 5.70% | 19.00% | -13.30 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -4.50% | 0.30% | -4.80 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.99% | 2.65% | +0.34 | ESCA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.38 | 5.59 | +0.79 | ESCA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ESCA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.9 | 60.3 | +1.60 | ESCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.8x | 21.7x | -2.90 | ESCA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $277.2M | $372.21B | -$371.94B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESCA REV | PG REV | ESCA GROSS % | PG GROSS % | ESCA FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $240.2M | $84.28B | 26.9% | 51.2% | $28.5M | $14.04B |
| FY 2024 | $251.5M | $84.04B | 24.7% | 51.4% | $34.0M | $16.52B |
| FY 2023 | $263.6M | $82.01B | — | — | $48.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESCA // BETA —
PG // BETA 0.87